miércoles, 8 de agosto de 2018

The Early Development of Judo Out of Disparate Jujitsu Schools


Luis Miguel Chong Chong has been a leader with many companies in North America, including Mexico City's Disruptiva Works, S.A. de C.V., as well as Ensi Group, in Los Angeles, California. Before beginning his career in business, Luis Miguel Chong Chong competed in judo for the Instituto Politécnico Nacional -National Polytechnic Institute of Mexico, and was junior national champion for years. 

The early history of judo begins in the 1500s, with takenouchi-ryu, a martial art that was foundational to what later became judo and jujitsu. This martial art was developed extensively by the samurai, as it was the only art to focus on self-defense without using a weapon. This deep study led to branching off of countless similar styles, such as kyushinryu, mirua-ryu, kito-ryu, and tenshin-shinyo-ryu. In the 1880s, amid significant political change in Japan, Dr. Jigoro Kano began to unify elements from these disparate styles into what is now known as judo.

Judo, unlike jujitsu, focused on development of mental and physical skill as a comprehensive education program as well as a competitive sport. Practitioners learned techniques such as kicks and advanced joint locks only in advanced study, as these techniques were considered too dangerous for competitive judo. Over the next 30 years, judo grew to become one of the world's most popular sports, and absorbed most leading jujitsu schools' techniques and practices, preserving them as form studies called kata for posterity.

sábado, 21 de julio de 2018

New Genome Studies Reveal Divergences among Great Apes


miércoles, 11 de julio de 2018

Report Points to Cognitive Computing Market Expansion


A respected Mexican entrepreneurial presence, Luis Miguel Chong Chong’s leadership experience extends to areas such as infrastructure, health sciences, and communication. Among Luis Miguel Chong Chong’s current areas of focus is big data and cognitive computing.

A recently released report by Transparency Market Research (TMR) brought attention to a global market dynamic in which cognitive computing industry competition is still relatively low. Major players such as IBM, Google, Cisco Systems, and Microsoft Corporation leverage economies of scale and past innovations to take advantage of burgeoning machine learning and artificial intelligence markets. 

Health care can be found at the forefront of industries in which such technologies are deployed, along with energy, telecom, manufacturing, media, and business verticals. With North America leading the way in terms of cognitive computing penetration, deployments by small-to-medium-sized companies and educational institutions are driving the largest regional gains. In tandem with this, the IT paradigm is rapidly shifting to cloud-based applications, with cyber security apps that have cognitive computing functions meeting a major market need.

sábado, 6 de enero de 2018

RISPR-Cas9 Tools Redefine Genetic Editing Potential


Luis Miguel Chong Chong serves as director of Disruptiva Works, S. A. de C. V., leading projects in the sustainable infrastructure and information and communication technologies sectors, With entrepreneurial experience extending to managing pharmaceutical products distribution and life sciences services, Luis Miguel Chong Chong has a longstanding interest in health care and human genomics. 

As reported in Forbes, one major global health care trend centers on the development of applications-focused CRISPR-Cas9 tools. High precision RNA-driven gene editing tools that are able to cut the DNA sequence accurately were introduced for commercial applications only five years after being introduced, an accelerated timeframe within the gene editing world. 

Able to accurately recognize specific animal, plant, and human DNA sequences, the technology employs endonuclease Cas9, a cutting enzyme, and provides scientists and clinicians with a precise, low-risk way of editing regions within the DNA sequence. With the inclusion of a preferred sequence of DNA within the edited region, desired traits in living beings are expressed. CRISPR’s commercial potential spans human genomics as well as animal and plant biotechnology and is expected to represent a $25 billion industry within the next 12 years.

This technology could be very useful in treating various genetic and chronic diseases, such as different types of cancers, cystic fibrosis (CF), sickle-cell disease, beta thalassemias, and blindness.